Wednesday, June 10, 2026

pharma Β· No medical condition.

BIAL - Portela

BIAL - Portela clinical programs β€” 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

TROFA, PT HQ
EMA registrant Type
Company details
Status
Public
HQ
TROFA, PT
Programs
4
Drugs
9
Patents
25
Intelligence Β· Clinical Programs

BIAL - Portela projects

4 ClinicalTrials.gov programs sponsored by BIAL - Portela.

BIAL - Portela has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. BIA-28-6156-113

    BIAL - Portela & Ca

    Healthy volunteers

    phase 1 other active

    1 trial
  2. BLCL-AMC-01

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial
  3. BLCL-AMC-02

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial
  4. BLCL-AMC-03

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does BIAL - Portela have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.